Press "Enter" to skip to content

Omega-3 for Depression; Naltrexone for Chronic Pain

Could schizophrenia be reliably diagnosed with an app one day? (New Scientist)

Omega-3 polyunsaturated fatty acids are helpful as adjunctive therapy for major depression, according to a new practice guideline issued by the International Society for Nutritional Psychiatry Research. (Psychotherapy and Psychosomatics)

Instagram and Facebook are taking measures to prevent minors from seeing posts promoting weight loss products in an attempt to prevent eating disorders. (Washington Post)

A new study suggests that the youngest kids in the class are more likely to be diagnosed with attention deficit-hyperactivity disorder (ADHD), depression, and intellectual disability. (JAMA Pediatrics)

Can low doses of naltrexone help treat chronic pain? (NPR)

People with bipolar disorder may also have increased cortical androgen activity. (Psychiatry Research)

Young children diagnosed with pediatric bipolar disorder, who also have a parent with a bipolar disorder diagnosis, are more likely to present with comorbid ADHD. (Psychiatry Research)

After preliminary results were presented at the 2019 American Psychiatric Association meeting, full results of the phase II CLARITY trial appeared in the Journal of Clinical Psychiatry this week. The study found pimavanserin (Nuplazid) succeeded as adjunctive treatment for patients with major depressive disorder.